DUO-MEDIHALER Drug Patent Profile
✉ Email this page to a colleague
When do Duo-medihaler patents expire, and when can generic versions of Duo-medihaler launch?
Duo-medihaler is a drug marketed by 3M and is included in one NDA.
The generic ingredient in DUO-MEDIHALER is isoproterenol hydrochloride; phenylephrine bitartrate. There are seventeen drug master file entries for this compound. Additional details are available on the isoproterenol hydrochloride; phenylephrine bitartrate profile page.
Summary for DUO-MEDIHALER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Patent Applications: | 3,859 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DUO-MEDIHALER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DUO-MEDIHALER
US Patents and Regulatory Information for DUO-MEDIHALER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | DUO-MEDIHALER | isoproterenol hydrochloride; phenylephrine bitartrate | AEROSOL, METERED;INHALATION | 013296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |